Capilliposide from promotes terminal differentiations and reverses paclitaxel resistance in A2780T cells of human ovarian cancer by regulating Fos/Jun pathway.

Journal: Chinese herbal medicines
Published Date: Sep 25, 2021

Abstract

OBJECTIVE: To investigate the potential effect of capilliposide (LCC) on the chemo sensitivity and the stemness of human ovarian cancer cells.

Authors

  • Ke Zhang
    Center for Radiation Oncology, Affiliated Hangzhou Cancer Hospital, Zhejiang University School of Medicine, Hangzhou 310001, China.
  • Hanyue Ying
    The Forth Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, China.
  • Ruping Zhao
    Center for Radiation Oncology, Affiliated Hangzhou Cancer Hospital, Zhejiang University School of Medicine, Hangzhou 310001, China.
  • Yuanyuan Chen
    Center for Radiation Oncology, Affiliated Hangzhou Cancer Hospital, Zhejiang University School of Medicine, Hangzhou 310001, China.
  • Qinghua Deng
    Center for Radiation Oncology, Affiliated Hangzhou Cancer Hospital, Zhejiang University School of Medicine, Hangzhou 310001, China.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals